Feature Story
iO Portfolio Companies Showcased at Largest Physician Innovation Event
AN ONLINE EVENT – Jan. 8-10, 2021 – IGS2021 (InnovatorMD Global Summit) is an attempt to showcase physician innovators' work from around the world, inspire others to learn, and ignite innovation in healthcare. iO portfolio companies OncoDisc, Otomagnetics and Surgical Automations are among the innovators to participate.
visit event page
More Client & Industry News
GS Lab and iO life science Partner to Accelerate Patient Centric Medical Device Development
Dec. 15, 2020 -- GS Lab, an emerging leader in the medical devices industry, and a leader in product engineering, today announced it is teaming up with iO life science, a design and development firm dedicated to transforming lives through the innovation of smart, connected, patient-centric devices.
press release
Alio Introduces Series of Studies for Clinical-Grade Noninvasive Wearable
Nov. 10, 2020 -- Today, Alio launched a new series of studies and partnerships for its noninvasive wearable which provides seamless, accurate and protected data. The technology, originally targeted for those with chronic conditions outside the clinical setting, can measure and be applied to a variety of industries ultimately improving understanding of health and performance for areas like athletics, military and more.
press release
How an Implantable Dialysis Device May Extend Life for People with Kidney Failure
Oct. 28, 2020 -- A few years ago, Nikhil Shah and Hiep Nguyen were touring the German Aerospace Center after giving a presentation about the future of surgery. One of the in-house researchers showed off a model of an implantable heart, and they thought — Why can’t we do that with a kidney?
full article

Oct. 13, 2020
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer

Sep. 21, 2020
Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant

Aug. 6, 2020
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
